Evaluating Repligen: Insights From 6 Financial Analysts
Portfolio Pulse from Benzinga Insights
Repligen (NASDAQ:RGEN) has been analyzed by six financial analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $188.33, slightly down from the previous $192.00. Analysts have adjusted their ratings and price targets, reflecting their views on Repligen's market performance. Despite a recent revenue decline, Repligen shows strong financial metrics like net margin, ROE, and ROA, and maintains a conservative debt approach.
September 26, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Repligen has received mixed analyst ratings, with a slight decrease in the average 12-month price target. Despite a revenue decline, the company maintains strong financial metrics, including net margin and ROE.
The mixed analyst ratings and slight decrease in price targets suggest a neutral short-term impact on Repligen's stock price. The company's strong financial metrics, such as net margin and ROE, provide a positive outlook, but the recent revenue decline poses a challenge.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100